Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 553

Similar articles for PubMed (Select 12660666)

1.

Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.

Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L.

Am Heart J. 2003 Mar;145(3):438-44.

PMID:
12660666
2.
3.

Discharge prescriptions following admission for acute myocardial infarction at tertiary care and community hospitals in Quebec.

Beck CA, Lauzon C, Eisenberg MJ, Huynh T, Dion D, Roux R, Racine N, Carignan S, Diodati JG, Charbonneau F, Lévesque C, Pouliot J J, Pilote L L.

Can J Cardiol. 2001 Jan;17(1):33-40.

PMID:
11173312
5.

Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?

Hudson M, Richard H, Pilote L.

Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):773-85.

PMID:
17486661
8.

Decade-long trends (1986 to 1997) in the medical treatment of patients with acute myocardial infarction: A community-wide perspective.

Spencer F, Scleparis G, Goldberg RJ, Yarzebski J, Lessard D, Gore JM.

Am Heart J. 2001 Oct;142(4):594-603.

PMID:
11579348
9.

Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.

Gislason GH, Rasmussen JN, Abildstrøm SZ, Gadsbøll N, Buch P, Friberg J, Rasmussen S, Køber L, Stender S, Madsen M, Torp-Pedersen C.

Eur Heart J. 2006 May;27(10):1153-8. Epub 2006 Jan 6.

11.

Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.

Filippi A, D'Ambrosio G, Giustini SE, Pecchioli S, Mazzaglia G, Cricelli C.

J Cardiovasc Med (Hagerstown). 2009 Sep;10(9):714-8. doi: 10.2459/JCM.0b013e32832c6110.

PMID:
19465867
13.

Use of secondary preventive medications after the first attack of acute coronary syndrome.

Salomaa V, Pääkkönen R, Hämäläinen H, Niemi M, Klaukka T.

Eur J Cardiovasc Prev Rehabil. 2007 Jun;14(3):386-91.

PMID:
17568237
14.

Impact of a critical pathway on acute myocardial infarction quality indicators.

Bestul MB, McCollum M, Stringer KA, Burchenal J.

Pharmacotherapy. 2004 Feb;24(2):173-8.

PMID:
14998217
15.

Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000.

Pilote L, Beck CA, Karp I, Alter D, Austin P, Cox J, Humphries K, Jackevicius C, Richard H, Tu JV; Canadian Cardiovascular Outcomes Research Team.

Can J Cardiol. 2004 Jan;20(1):61-7.

PMID:
14968144
16.

Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.

Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum A, Flather MD, Granger CB, Erickson S, White K, Steg PG.

Am J Med. 2004 Jul 15;117(2):73-81.

PMID:
15234641
17.
18.

Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.

Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM.

Can J Cardiol. 2005 May 1;21(6):485-8.

PMID:
15917876
19.
20.

Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: a multinational perspective.

Goldberg RJ, Spencer FA, Steg PG, Flather M, Montalescot G, Gurfinkel EP, Kennelly BM, Goodman SG, Dedrick R, Gore JM; Global Registry of Acute Coronary Events Investigators.

Arch Intern Med. 2007 Sep 10;167(16):1766-73.

PMID:
17846396
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk